MARKERS FOR PROGRESSION TO CHRONIC KIDNEY DISEASE - ROLE OF KALLIKREIN

进展为慢性肾脏病的标志物 - 激肽释放酶的作用

• 批准号: 7950970
• 负责人: Ravindra L. Mehta
• 金额: $ 0.34万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-12-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7950970
• 关键词: Acute Renal Failure with Renal Papillary Necrosis; Chronic Kidney Failure; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Kininogenase; Recovery; Research; Research Personnel; Resources; Role; Source; United States National Institutes of Health; Urinary Kallikrein; progression marker

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Demonstrate that decreased urinary kallikrein activity is associated with incomplete recovery from acute kidney injury

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 证明尿激肽释放酶活性降低与急性肾损伤恢复不完全相关